Revlimid and Actemra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Revlimid (lenalidomide) and Actemra (tocilizumab). Common drug interactions include infusion related reaction among females and disease progression among males.

The phase IV clinical study analyzes what interactions people have when they take Revlimid and Actemra. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

What is Actemra?

Actemra has active ingredients of tocilizumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 102,759 Actemra users. Check the latest studies of Actemra.

On Jul, 12, 2026

26 people who take Revlimid and Actemra together, and have interactions are studied.

What are the common drug interactions of Revlimid and Actemra, by gender? *:

female:

Infusion related reaction
Abdominal distension
Allergic respiratory symptom
Contusion (a type of hematoma of tissue in which capillaries)
Dyspnoea (difficult or laboured respiration)
Excessive granulation tissue (excessive collagen-rich tissue which forms at the site of an injury)
Hypersensitivity
Hypertension (high blood pressure)
Ill-defined disorder
Inflammation

male:

Disease progression
Jc virus infection
Fatigue (feeling of tiredness)
Cardiac failure congestive
Death
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Hypotonia (low muscle tone)
Oropharyngeal pain
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Revlimid and Actemra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Disease progression
Jc virus infection
Mantle cell lymphoma recurrent (cancer of lymphocytes, a type of white blood cell- recurrent)
Abdominal distension
Allergic respiratory symptom
Contusion (a type of hematoma of tissue in which capillaries)
Dyspnoea (difficult or laboured respiration)
Excessive granulation tissue (excessive collagen-rich tissue which forms at the site of an injury)
Hypersensitivity
Hypertension (high blood pressure)

60+:

Arthralgia (joint pain)
Cough
Gout (uric acid crystals building up in the body)
Hypoaesthesia (reduced sense of touch or sensation)
Infusion related reaction
Nausea (feeling of having an urge to vomit)
Weight decreased
Cardiac failure congestive
Swelling
Neuropathy peripheral (surface nerve damage)

What are the existing conditions these people have? *

Mantle Cell Lymphoma Refractory (relapsed cancer of lymphocytes, a type of white blood cell): 6 people, 23.08%
High Blood Pressure: 6 people, 23.08%
Fever: 6 people, 23.08%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 5 people, 19.23%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 11.54%
Pain: 2 people, 7.69%
Nausea (feeling of having an urge to vomit): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and Actemra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously